Skip to main content
logo
Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · Real-Time Price · USD
4.500
+0.200 (4.65%)
Mar 31, 2026, 4:00 PM EDT - Market closed

Arbutus Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
880926621425367564
Market Cap Growth
41.54%49.08%46.27%15.75%-34.95%77.16%
Enterprise Value
792.37838.25504.19306.96232.14427.21
Last Close Price
4.504.813.272.502.333.89
PE Ratio
--28.29-8.61-5.68-5.07-4.69
PS Ratio
62.4665.76100.6623.419.4051.33
PB Ratio
11.3112.096.384.012.683.33
P/TBV Ratio
11.2612.046.233.912.572.44
P/FCF Ratio
--23.36-9.55-4.88-10.23-8.25
P/OCF Ratio
--23.36-9.58-4.94-10.38-8.35
EV/Sales Ratio
56.2659.5281.7016.925.9538.88
EV/EBITDA Ratio
--22.18-6.73-4.00-3.63-5.95
EV/EBIT Ratio
--21.97-6.61-3.93-3.55-5.81
EV/FCF Ratio
--21.15-7.75-3.53-6.47-6.25
Debt / Equity Ratio
0.050.050.060.080.090.11
Debt / EBITDA Ratio
-0.11-0.11-0.08-0.11-0.20-0.26
Debt / FCF Ratio
-0.11-0.11-0.09-0.10-0.35-0.28
Net Debt / Equity Ratio
-1.14-1.14-1.20-1.11-0.98-0.80
Net Debt / EBITDA Ratio
2.312.311.561.532.101.90
Net Debt / FCF Ratio
2.202.201.791.353.752.00
Asset Turnover
0.120.120.040.110.200.06
Quick Ratio
15.4715.478.015.684.5113.92
Current Ratio
15.7315.738.155.874.6014.32
Return on Equity (ROE)
-38.52%-38.52%-68.76%-59.99%-45.35%-56.19%
Return on Assets (ROA)
-33.72%-33.72%-55.28%-45.97%-30.50%-43.05%
Return on Invested Capital (ROIC)
9636.36%9636.36%-1582.23%-384.71%-172.25%-342.03%
Return on Capital Employed (ROCE)
-37.28%-37.28%-64.13%-54.91%-36.79%-45.84%
Earnings Yield
-3.81%-3.53%-11.62%-17.60%-19.74%-21.34%
FCF Yield
-4.51%-4.28%-10.47%-20.47%-9.78%-12.12%
Buyback Yield / Dilution
-3.23%-3.23%-11.84%-9.95%-42.07%-40.10%
Total Shareholder Return
-3.23%-3.23%-11.84%-9.95%-42.07%-40.10%
Updated Mar 23, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q